Literature DB >> 12010070

Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy.

Daniëlle I M Kuijpers1, Monique R T M Thissen, Martino H A Neumann.   

Abstract

The incidence of basal cell carcinoma is rapidly increasing and a number of treatment modalities are available. Treatment of basal cell carcinoma includes both surgical and nonsurgical approaches, some of which are traditional, and others experimental. The treatment modality utilized is dependent on both the tumor type and the patient. In order to choose between therapies, evidence-based research is necessary. In an extensive review of the literature concerning treatment options for patients with basal cell carcinoma, we found that there are a limited number of comparative, prospective, randomized, long-term follow-up studies. Based on the results of the available studies, surgical excision, Mohs surgery and cryosurgery are the three standard therapies of choice. Other treatment modalities should be considered secondary choices. There are also promising new treatment options, such as photodynamic therapy, which need further investigation. Special attention is needed when treating the more aggressive subtypes of the disease, such as the micronodular, infiltrative, adenoid and morpheic forms of basal cell carcinoma, as well as bigger basal cell carcinomas and basal cell carcinoma recurrences.

Entities:  

Mesh:

Year:  2002        PMID: 12010070     DOI: 10.2165/00128071-200203040-00003

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  10 in total

Review 1.  A Review of the Global Guidelines on Surgical Margins for Nonmelanoma Skin Cancers.

Authors:  Amanda F Nahhas; Chase A Scarbrough; Shannon Trotter
Journal:  J Clin Aesthet Dermatol       Date:  2017-04

2.  Cryotherapy as an Effective therapeutic Option in Patients with Nodular Basal Cell Carcinoma - Case Report.

Authors:  Eva Krishna Sutedja; Panji Respati Satjamanggala; Endang Sutedja; Kartika Ruchiatan
Journal:  Int Med Case Rep J       Date:  2022-10-11

3.  Management of Basal Cell Carcinomas: Clinical Experience.

Authors:  İrfan Kara; Alperen Vural; Metin Ünlü; Furkan Şan; Gülten Benan Göçer; Muhammed Gazi Yıldız
Journal:  Turk Arch Otorhinolaryngol       Date:  2022-05-12

4.  Mohs micrographic surgery for periocular skin tumours in Ireland.

Authors:  M P Treacy; N C Wynne; J L Gale; E Duignan; B Moran; A M Flynn; P Ormond; R Barry; R Khan; P Moriarty; L Cassidy
Journal:  Ir J Med Sci       Date:  2015-07-11       Impact factor: 1.568

5.  Patient satisfaction after treatment of nonmelanoma skin cancer.

Authors:  Maryam M Asgari; Daniel Bertenthal; Saunak Sen; Anju Sahay; Mary-Margaret Chren
Journal:  Dermatol Surg       Date:  2009-05-08       Impact factor: 3.398

6.  High-risk basal cell carcinoma excision in primary care: a retrospective observational study of compliance with NICE guidance.

Authors:  Simon John Cole; Rachel Howes; Chris Meehan; Richard Cole
Journal:  BMJ Open       Date:  2019-02-22       Impact factor: 2.692

7.  Clinicopathological Factors Associated with Incomplete Excision of High-risk Basal Cell Carcinoma.

Authors:  Hannah Ceder; Annie Ekström; Lajla Hadzic; John Paoli
Journal:  Acta Derm Venereol       Date:  2021-07-13       Impact factor: 3.875

8.  Mohs Micrographic Surgery for Primary Versus Recurrent or Incompletely Excised Facial High-risk Basal Cell Carcinomas.

Authors:  Hannah Ceder; Malin Grönberg; John Paoli
Journal:  Acta Derm Venereol       Date:  2021-02-02       Impact factor: 3.875

9.  Aminolevulinic Acid-photodynamic therapy of Basal cell carcinoma and factors affecting the response to treatment: a clinical trial.

Authors:  Zohreh Tehranchinia; Hoda Rahimi; Mahsa Seyed Ahadi; Maral Seyed Ahadi
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

10.  The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital.

Authors:  Luciana Takata Pontes; Rafael Fantelli Stelini; Maria Leticia Cintra; Renata Ferreira Magalhães; Paulo Eduardo N F Velho; Aparecida Machado Moraes
Journal:  Clinics (Sao Paulo)       Date:  2015-11       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.